109 related articles for article (PubMed ID: 14752277)
1. The cyclin D3 knockout: a pound of redundancy with a dash of tissue specificity.
Diehl JA
Cancer Biol Ther; 2004 Feb; 3(2):162-4. PubMed ID: 14752277
[TBL] [Abstract][Full Text] [Related]
2. Requirement for cyclin D3 in lymphocyte development and T cell leukemias.
Sicinska E; Aifantis I; Le Cam L; Swat W; Borowski C; Yu Q; Ferrando AA; Levin SD; Geng Y; von Boehmer H; Sicinski P
Cancer Cell; 2003 Dec; 4(6):451-61. PubMed ID: 14706337
[TBL] [Abstract][Full Text] [Related]
3. No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cells.
Weng AP; Aster JC
Cancer Cell; 2003 Dec; 4(6):417-8. PubMed ID: 14706330
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
5. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
Santamaria D; Ortega S
Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content.
Datta NS; Williams JL; Long MW
Cell Growth Differ; 1998 Aug; 9(8):639-50. PubMed ID: 9716181
[TBL] [Abstract][Full Text] [Related]
7. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
8. Living with or without cyclins and cyclin-dependent kinases.
Sherr CJ; Roberts JM
Genes Dev; 2004 Nov; 18(22):2699-711. PubMed ID: 15545627
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of cyclins A, B1, D3, and E in asynchronous and synchronous MOLT-4 cells of G1 phase].
Yu CZ; Feng YD; Tao DD; Yu Y; Wu JH; Gong JP
Ai Zheng; 2005 Feb; 24(2):170-4. PubMed ID: 15694027
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the "Cdk-centric" view of the mammalian cell cycle.
Malumbres M
Cell Cycle; 2005 Feb; 4(2):206-10. PubMed ID: 15655365
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
[TBL] [Abstract][Full Text] [Related]
14. [Cell cycle and parathyroid tumor].
Matsushime H
Nihon Rinsho; 1995 Apr; 53(4):844-9. PubMed ID: 7752470
[TBL] [Abstract][Full Text] [Related]
15. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
16. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
17. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes.
Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S
J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775
[TBL] [Abstract][Full Text] [Related]
18. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
19. A unique function for cyclin D3 in early B cell development.
Cooper AB; Sawai CM; Sicinska E; Powers SE; Sicinski P; Clark MR; Aifantis I
Nat Immunol; 2006 May; 7(5):489-97. PubMed ID: 16582912
[TBL] [Abstract][Full Text] [Related]
20. Control of G1 progression by D-type cyclins: key event for cell proliferation.
Kato JY
Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
